Entegris Work in process increased by 27.4% to $70.60M in Q1 2026 compared to the prior quarter. Year-over-year, this metric grew by 28.8%, from $54.80M to $70.60M. Over 5 years (FY 2020 to FY 2025), Work in process shows an upward trend with a 11.4% CAGR. This increase may warrant attention — for this metric, lower values are generally preferred.
An increase may indicate production bottlenecks or scaling efforts, while a decrease suggests efficient throughput or reduced manufacturing activity.
Represents the value of goods that have entered the production process but are not yet finished. For a manufacturer like...
Peers in medical device manufacturing typically maintain lean WIP levels to optimize cash conversion cycles.
inv_work_in_progress| Q2 '21 | Q3 '21 | Q4 '21 | Q1 '22 | Q2 '22 | Q3 '22 | Q4 '22 | Q1 '23 | Q2 '23 | Q3 '23 | Q4 '23 | Q1 '24 | Q2 '24 | Q3 '24 | Q4 '24 | Q1 '25 | Q2 '25 | Q3 '25 | Q4 '25 | Q1 '26 | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Value | $37.57M | $42.54M | $40.26M | $47.97M | $49.87M | $63.45M | $60.18M | $58.89M | $55.98M | $51.60M | $49.70M | $54.97M | $55.12M | $56.86M | $59.60M | $54.80M | $48.10M | $51.90M | $55.40M | $70.60M |
| QoQ Change | — | +13.2% | -5.4% | +19.1% | +4.0% | +27.2% | -5.2% | -2.2% | -4.9% | -7.8% | -3.7% | +10.6% | +0.3% | +3.1% | +4.8% | -8.1% | -12.2% | +7.9% | +6.7% | +27.4% |
| YoY Change | — | — | — | — | +32.7% | +49.2% | +49.5% | +22.8% | +12.3% | -18.7% | -17.4% | -6.6% | -1.5% | +10.2% | +19.9% | -0.3% | -12.7% | -8.7% | -7.0% | +28.8% |
| % of Inventories | 9.7% | 9.9% | 8.5% | 8.8% | 8.5% | 7.7% | 7.4% | 7.1% | 7.6% | 7.8% | 8.2% | 8.8% | 8.7% | 8.8% | 9.3% | 8.2% | 6.9% | 8.0% | 8.6% | 11.0% |
| Share Change | — | +0.2pp | -1.4pp | +0.3pp | -0.2pp | -0.8pp | -0.3pp | -0.3pp | +0.5pp | +0.2pp | +0.4pp | +0.6pp | -0.1pp | +0.1pp | +0.5pp | -1.2pp | -1.2pp | +1.1pp | +0.6pp | +2.3pp |